Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes

Pulmonary arterial hypertension (PAH) has a high morbidity rate and is fatal if left untreated. Increasing evidence supports early intervention, possibly with initial combination therapy. PAH-specific pharmaceuticals, however, are expensive and may have serious adverse effects, particularly when use...

Descripción completa

Detalles Bibliográficos
Autores principales: Burger, Charles D, Ghandour, Mohamedanwar, Padmanabhan Menon, Divya, Helmi, Haytham, Benza, Raymond L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703162/
https://www.ncbi.nlm.nih.gov/pubmed/29200882
http://dx.doi.org/10.2147/CEOR.S119117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703162/
https://www.ncbi.nlm.nih.gov/pubmed/29200882
http://dx.doi.org/10.2147/CEOR.S119117

Ejemplares similares